Some biological characteristics and features of the mitotic regime of basal-like breast cancer living in the south-east of Ukrainе
Current treatment regimens for patients with breast cancer should consider molecular genetic type of tumor. To identify aggressive tumors in medical practice assess the proliferation marker Ki-67 and apoptosis marker p53, but there are no data about its prognostic value in patients BLBC living in the south-east ofUkraine. For low-grade tumors, which include BLBC, characterized by a high degree of mitotic activity. In patients with BLBC in more than 50 % cases there was detected infiltrating ductal carcinoma. The high degree of aggression BLBC in the south-east ofUkraineputs its study on a par with the major problems in oncoecology.
Shchepotyn, Y. B., Zotov, A. S., & Liubota, Y. Y. Faktorы ryska razvytyia mestnыkh retsydyvov ynvazyvnoho raka hrudnoi zhelezы . Onkolohyia, 4 (12), 347–350.
Furuse, M., & Fujita, K. (1998). Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol, 7(141), 1539–1550.
Perou, C. M., Sorlie, T., & Eisen, M. B. (2000). Molecular portraits of human breast tumours. Nature, 406, 747–752.
Prat, A., Perou, C. M., & Prat, A. (2009). Mammary development meets cancer genomics. Nat Med, 15, 842–844.
Rouzier, R., Perou, C., & Symmans, W. (2005). Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer. Res, 85.
Sorlie, T., Perou, C. M., & Tibshirani, R. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA, 98, 10869–10874.
Sorlie, T., Tibshirani, R., & Parker, J. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA, 100, 8418–8423.
Sotiriou, C., Neo, S. Y., & McShane, L. M. (2003). Breast cancer classification and prognosis based on gene expression profiles from a population based study. Proc. Natl. Acad. Sci. USA, 10393–10398.
Tang, P., Skinner, K. A., & Hicks, D. G. (2009). Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready. Diagn. Mol. Pathol, 18, 125–132.
Tischkowitz, M., Brunet, J. S., & Begin, L. R. (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer, 1 (7), 134.
FindPatent. ru-patentnыi poysk, 20122016 http://www.findpatent.ru/patent/228/2282402.html.
Copyright (c) 2016 Medical and Clinical Chemistry
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.